By Nick Smith
Friday 29th November 2002 |
Text too small? |
The Health and Nutrition unit, which opened in Auckland yesterday, incorporates existing products from three legacy companies into one "specialty milk components innovator."
Chief executive Craig Norgate said the unit aimed to become the leader in the development and commercialisation of "bio-active ingredients for health and wellness."
Its opening was one of the key themes from "The Fonterra Strategy" and is expected to double existing earnings to about $80 million, he said.
Key markets for the specialty ingredients products include the US, Japan, Korea and China.
The "bio-actives market" had huge potential and "in the US alone, we expect to see growth double to a value of more than US$60 billion in the next four years," he said.
"By focusing on specialised research and development now, we will be well-placed to capture a good share of this growth, Mr Norgate said.
"The opportunities are virtually endless and we now have a strategy and discovery unit in place to identify, capture and maximise these returns to shareholders and ensuring that we stay ahead of the competition."
Key areas for the unit, headed by Patrick Geals from pharmaceutical giants Glaxo SmithKline and Novartis, to investigate include finding products that show benefits for the immune system, bone health, dermatology, gastrointestinal, sports and animal health.
No comments yet
ASB workers to strike as bank proposes an effective pay cut
Rising tides, sinking stocks: study explores cost of climate change
May 2nd Morning Report
AGL - Change in Senior Management
Devon Funds Morning Note - 01 May 2024
Rick Christie to step-aside as a non-executive director
CHI - New customer contract to upgrade Marsden Point
Synlait announces changes to Board of Directors
May 1st Morning Report
Devon Funds Morning Note - 30 April 2024